Clinical trial
HUPS: Hyalgan Use in Painful Shoulder
NCT00377624 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00377624 |
|---|---|
| Title | HUPS: Hyalgan Use in Painful Shoulder |
| Official title | Sodium Hyaluronate for Treatment of Chronic Painful Shoulder With Limitation of Motion Due to Glenohumeral Joint Osteoarthritis, Rotator Cuff Tear and/or Primary or Secondary Adhesive Capsulitis |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis of Shoulder |
| Intervention type | Drug |
| Interventions | sodium hyaluronate |
| Enrollment | 602 |
| Start date | Jan 1, 2002 |
| Completion | Sep 1, 2004 |
| First posted | Sep 18, 2006 |
| Last update posted | Jan 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: